NCT07038473

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 3,500 (estimated)
• Sponsor: Sanofi · Industry
• Sex: All
• Age: 18 Months – 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).

Conditions

• Type 1 Diabetes

Interventions

Type	Name	Description
PROCEDURE	Investigational Procedure	It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands. Study without any Investigational Medicinal Product (IMP) administration.

Timeline

• Start date: 2025-12-17
• Primary completion: 2026-12-25
• Completion: 2026-12-25
• First posted: 2025-06-26
• Last updated: 2026-02-19

Locations

2 sites across 2 countries: Saudi Arabia, United Arab Emirates